¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cell adhesion kinase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • interdental cell
    û°¢Ä¡¾Æ»çÀ̼¼Æ÷, Ä¡°£¼¼Æ÷
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
  • interstitial cell
    »çÀÌÁú¼¼Æ÷, °£Áú¼¼Æ÷
  • interstitial cell-stimulating hormone
    »çÀÌÁú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó, °£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó
  • interstitial plasma cell pneumonia
    »çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
  • Jurkat cell
    Àúı¼¼Æ÷
  • juvenile cell
    À¯¾à¼¼Æ÷
  • juxtaglomerular cell tumor
    Å丮°ç¼¼Æ÷Á¾¾ç, »ç±¸Ã¼¿·¼¼Æ÷Á¾¾ç
  • Kupffer¡¯s cell
    ÄíÆÛ¼¼Æ÷, º°Å«Æ÷½Ä¼¼Æ÷
  • killer cell
    »ìÇØ¼¼Æ÷
  • Langerhans cell
    ¶û°Ô¸£Çѽº¼¼Æ÷
  • Langerhans cell histiocytosis
    ¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
  • large cell acanthoma
    Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ´ë¼¼Æ÷±Ø¼¼Æ÷Á¾
  • large cell carcinoma
    ´ë¼¼Æ÷¾ÏÁ¾, Å«¼¼Æ÷¾ÏÁ¾
  • lepra cell
    ³ªº´¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • myeloma cell
    °ñ¼öÁ¾¼¼Æ÷
  • myoepithelial cell
    ±ÙÀ°»óÇǼ¼Æ÷
  • myoid cell
    À¯»ç±ÙÀ°¼¼Æ÷
  • natural killer cell
    ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷, ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷
  • nerve cell
    ½Å°æ¼¼Æ÷
  • neural crest cell
    ½Å°æ´É¼±¼¼Æ÷
  • neuroendocrine cell
    ½Å°æ³»ºÐºñ¼¼Æ÷
  • neuroepithelial cell
    ½Å°æ»óÇǼ¼Æ÷
  • neuroglial cell
    ½Å°æ¾Æ±³¼¼Æ÷
  • neurosecretory cell
    ½Å°æºÐºñ¼¼Æ÷
  • nevus cell
    ¸ð¹Ý¼¼Æ÷
  • nodal cell
    °áÀý¼¼Æ÷
  • nucleated cell
    À¯ÇÙ¼¼Æ÷
  • null cell
    ¹«Ç¥Áö¼¼Æ÷
  • nurse cell
    (¢¡supporting cell) ¹öÆÀ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • helper T cell
    º¸Á¶ T ¼¼Æ÷
  • helper cell
    º¸Á¶¼¼Æ÷
  • helper cell
    Á¶·Â¼¼Æ÷, º¸Á¶¼¼Æ÷
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hematopoietic cell transplantation
    Á¶Ç÷¼¼Æ÷À̽Ä(¡­á¬øàì¹ãÕ)
  • hematopoietic stem cell
    Á¶Ç÷°£¼¼Æ÷
  • hemolytic plaque-forming cell
    ¿ëÇ÷¹Ý Çü¼º¼¼Æ÷, ¿ëÇ÷ÇöóÅ© Çü¼º¼¼Æ÷
  • hensens cell
    ¹Ù±ù°æ°è¼¼Æ÷
  • hepatic cell
    °£¼¼Æ÷(ÊÜá¬øà).
  • hepatic cell cord
    °£¼¼Æ÷ÁÙ, °£¼¼Æ÷»è(¡­ßã).
  • heteroploid cell line
    À̼öü¼¼Æ÷°è
  • heterotrophic cell
    Á¾¼Ó¿µ¾ç¼¼Æ÷.
  • high peroxidase cell
    °íÆä·Ï½Ã´Ù¾ÆÁ¦¼¼Æ÷
  • hilus cell tumor
    ¹®¼¼Æ÷Á¾
  • hilus cell ³ª
    ¹®¼¼Æ÷(Ú¦á¬øà).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • cell lethality
    ¼¼Æ÷Ä¡»çÀ²
  • cell like colloidal drop
    ¼¼Æ÷¾çÄÝ·ÎÀ̵å¾×Àû.
  • cell line
    ¼¼Æ÷°è, ¼¼Æ÷ÁÖ
  • cell line
    ¼¼Æ÷°è(á¬øàͧ).
  • cell line
    ¼¼Æ÷°è(á¬øàͧ).
  • cell line, established
    È®¸³¼¼Æ÷ÁÖ
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • cell loss factor
    ¼¼Æ÷¼Ò½Ç°è¼ö
  • cell lysis
    ¼¼Æ÷¿ëÇØ
  • cell mass
    ¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
  • cell mass
    ¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
  • cell matrix
    ¼¼Æ÷±âÁú
  • cell maturation
    ¼¼Æ÷¼º¼÷
  • cell mediated hypersensitivity
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • cell mediated immunity
    ¼¼Æ÷¼º¸é¿ª.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
HSVtk herpes simplex virus thymidine kinase
ITPK inositol 1,4,5-triphosphate-3-kinase
ITPKA inositol 1,4,5-triphosphate-3-kinase A
ITPKB inositol 1,4,5-triphosphate-3-kinase B
KAF conglutinogen-activating factor; killer-assisting factor; kinase activating factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ICAM I intercellular adhesion molecule I
MIDAS metal ion dependent adhesion site
sICAM-1 soluble intracellular adhesion molecule 1
VCAM-1 vascular cellular adhesion molecule 1
ES cell embryonic stem cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myoid cell
    ±ÙÀ°¾ç ¼¼Æ÷
  • natural kil1er cell
    ÀÚ¿¬ »ì¼¼Æ÷
    ¼±Ãµ¼º ¸é¿ªÀÇ Áß¿ä ÀÎÀÚ. ¼¼Æ÷ ³»¿¡ azuro
  • nerre cell body
    ½Å°æ¿øÃ¼, ½Å°æ ¼¼Æ÷ü
  • nerve cell
    ½Å°æ ¼¼Æ÷
    ´º·±¿¡¼­ µ¹±â¸¦ Á¦¿ÜÇÑ ºÎºÐ. ³ÐÀº Àǹ̷δ ´º·±°ú °°Àº ¶æÀ¸·Î ¾²ÀÌÁö¸¸ Á¼Àº Àǹ̷Π½Å°æ ¼¼Æ÷¸¦ ¼¼Æ÷ü
  • nerve cell layer
    ½Å°æ ¼¼Æ÷ Ãþ
  • neuroglial cell
    ½Å°æ¾Æ±³¼¼Æ÷, ½Å°æ ±³¼¼Æ÷
  • neuronal cell membrane
    ´º¿ì·± ¼¼Æ÷¸·
  • nh-cell ; °©»ó¼± ¹æ¿¡ ÀÖ´Â °ÍÀ¸·Î °¡Á¤µÇ´Â ½Å°æ È£¸£¸ó ¼¼Æ÷.

    Ni

    ´ÏÄÌ
    nickelÀÇ ¿ø¼Ò ±âÈ£.
  • Niemann Pick's cell
    ´Ï¸¸-ÇÇÅ© ¼¼Æ÷
    ·¹½ÃƾÀ» ´Ù·®À¸·Î ÇÔÀ¯ÇÏ´Â ¼¼Æ÷.
  • nociceptive dorsal horn cell
    Ä§ÇØ ¼ö¿ë¼º Èİ¢ ¼¼Æ÷, À¯ÇØ ¼ö¿ë¼º Èİ¢ ¼¼Æ÷
  • nociceptive projection cell
    Ä§ÇØ ¼ö¿ë¼º Åõ»ç ¼¼Æ÷, À¯ÇØ ¼ö¿ë¼º Åõ»ç ¼¼Æ÷
  • nociceptive-specific cell
    Ä§ÇØ ¼ö¿ë-ƯÀ̼º ¼¼Æ÷, À¯ÇØ ¼ö¿ë-ƯÀ̼º ¼¼Æ÷
  • non-caseating epithelioid cell granulomata
    ºñ°Ç¶ô¼º À¯»óÇÇ ¼¼Æ÷ À°¾ÆÁ¾
  • non-keratinized squamous cell carcinoma
    ºñ°¢È­¼º ÆíÆò »óÇÇ ¼¼Æ÷ ¾Ï
  • non-nociceptive cell
    ºñÄ§ÇØ ¼ö¿ë¼º ¼¼Æ÷, ºñÀ¯ÇØ ¼ö¿ë¼º ¼¼Æ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
sty1 protein kinase <enzyme> A map kinase homolog; 86% identical to hog1 and 57% identical to csbp1 map kinase; genbank x89262
Registry number: EC 2.7.1.-
Synonym: sty1 gene product
(26 Jun 1999)
STY kinase <enzyme> A dual specificity kinase of the lammer kinase family; from embryonal carcinoma cell line.
Registry number: EC 2.7.1.-
Synonym: clk kinase
(26 Jun 1999)
nonreceptor protein tyrosine kinase <enzyme> Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand binding domain, a single transmembrane domain and an intracellular tyrosine kinase domain and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases.
(18 Nov 1997)
Nrk protein kinase <enzyme> Regulation is under translational control; involved in trypanosoma brucei differentiation; nrk locus has two homologous genes nrka and nrkb (97% identity); amino acid sequence has been determined
Registry number: EC 2.7.10.-
Synonym: nrk protein
(26 Jun 1999)
NS5A-associated kinase <enzyme> Involved in the phosphorylation of the hepatitis c virus ns5a nonstructural protein in vitro and in vivo
Registry number: EC 2.7.10.-
(26 Jun 1999)
nucleoside-diphosphate kinase <enzyme> A phosphotransferase enzyme that is found in mitochondria and in the soluble cytoplasm of cells.
It catalyses reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribonucleoside triphosphates and deoxyribonucleoside triphosphates can act as a donor.
Chemical name: ATP:nucleoside-diphosphate phosphotransferase
Registry number: EC 2.7.4.6
(12 Dec 1998)
nucleoside-phosphate kinase <enzyme> An enzyme that catalyses reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., ump, to form ADP and udp. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor.
Chemical name: ATP:nucleoside-phosphate phosphotransferase
Registry number: EC 2.7.4.4
(12 Dec 1998)
nucleoside triphosphate-adenylate kinase <enzyme> Other nucleoside triphosphates may replace GTP as substrate
Registry number: EC 2.7.4.10
Synonym: GTP-AMP phosphotransferase, AMP-GTP phosphotransferase
(26 Jun 1999)
DAP kinase <enzyme> A potential mediator of the gamma interferon-induced cell death; has 8 ankyrin repeats; mw 160 kD; genbank x76105
Registry number: EC 2.7.10.-
(26 Jun 1999)
D-arabino-1-kinase <enzyme> Do not confuse with d-arabinokinase, which places phosphate group at 5 position; l-arabinokinase places phosphate group at 1 position of l-arabinose (EC 2.7.1.46)
Registry number: EC 2.7.1.-
(26 Jun 1999)
Swe1 kinase <enzyme> Analog of wee1 protein; phosphorylates tyr residue 19 of cdc28 and inhibits its activity; from saccharomyces cerevisiae
Registry number: EC 2.7.1.-
Synonym: swe1 gene product
(26 Jun 1999)
deoxycytidine kinase <enzyme> An enzyme that catalyses reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (herpes virus hominis).
Chemical name: NTP:deoxycytidine 5'-phosphotransferase
Registry number: EC 2.7.1.74
(12 Dec 1998)
deoxyguanosine kinase <enzyme> ATP serves as phosphate donor; various deoxyribonucleoside phosphates and ribonucleoside phosphates are formed
Registry number: EC 2.7.1.113
Synonym: AMP deoxyguanosine phosphotransferase
(26 Jun 1999)
deoxynucleoside-phosphate kinase <enzyme> Deoxynucleotide kinase was en to nucleoside monophosphate kinases 1982-93; deoxynucleoside monophosphate kinase was en to nucleoside monophosphate kinases 1983-93
Registry number: EC 2.7.4.13
Synonym: deoxynucleotide kinase, deoxynucleoside monophosphate kinase, deoxynucleoside-monophosphate kinase, deoxyribonucleoside 5'-monophosphate kinase, 5-dnmp kinase, deoxyribonucleoside monophosphokinase
(26 Jun 1999)
diacylglycerol kinase <enzyme> An enzyme of the transferase class that catalyses the phosphorylation of a diacylglycerol to form a phosphatidate, using ATP as a phosphate donor.
Chemical name: ATP:1,2-diacylglycerol 3-phosphotransferase
Registry number: EC 2.7.1.107
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á